Pipeline
A platform for
multiple indications
BODUS is being developed for neurological and psychiatric conditions with high unmet medical needs. Our initial focus is on chronica insomnia, with additional indications in development.
| Indication | Research | Preclinical | Clinical PoC | Pivotal | CE/FDA Mark | Market |
|---|---|---|---|---|---|---|
| Chronica InsomniaLead program |
|
|||||
| Stroke / NeurorehabilitationMotor recovery |
|
|||||
| Anxiety / Depression |
|
|||||
| PTSD |
|
|||||
| Pain / Migraine |
|
|||||
| Cognitive disorders |
|
|||||
Restoring function.
Improving lives.
A platform for
a brighter tomorrow.
